These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1146004)

  • 21. [Hematologic changes in patients under long-term hemodialysis and hemofiltration treatment with special reference to serum concentrations of folic acid and vitamin B 12].
    Minar E; Zazgornik J; Bayer PM; Lanschützer H; Mengele K; Marosi L
    Schweiz Med Wochenschr; 1984 Jan; 114(2):48-53. PubMed ID: 6367027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum urea-creatinine ratio as a prognostic index in hemodialysis patients.
    Oksa H; Pasternack A; Pasanen M
    Clin Nephrol; 1987 Mar; 27(3):125-30. PubMed ID: 3568461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
    ASAIO J; 1992; 38(3):M593-5. PubMed ID: 1457929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of phytohemagglutinin on lymphocytes from patients with renal insufficiency in in vitro cultures.
    Szewczyk Z; Melcer H
    Arch Immunol Ther Exp (Warsz); 1970; 18(4):460-72. PubMed ID: 5478578
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound.
    Giannattasio P; Minutolo R; Bellizzi V; Di Iorio BR; Scigliano R; Zamboli P; Venditti G; Manganelli R; De Simone W; Aucella F; Stallone C; Spiezia S; Conte G; De Nicola L
    Am J Kidney Dis; 2006 Jun; 47(6):1045-54. PubMed ID: 16731300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M; Akca R; Sarandol E; Dilek K
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of suppressor cells in normal lymphocytes by uremic serum.
    Weissgarten J; Modai D; Cohen N; Averbukh Z; Shaked U; Tieder M; Peller S; Kaufman S
    Int Arch Allergy Appl Immunol; 1986; 81(2):180-3. PubMed ID: 2944846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-hemodialyzer interactions.
    Schindhelm K; Farrell PC
    Trans Am Soc Artif Intern Organs; 1978; 24():357-66. PubMed ID: 716025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of trasylol on the concentration of middle-sized molecules of urea and creatinine in the plasma in acute experimental uremia].
    Madry K; Lutz W; Grande G
    Pol Tyg Lek; 1978 Jan; 33(1):5-8. PubMed ID: 306100
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of middle-sized molecule aggregates from dialysate of uremic patients on lymphocyte transformation in vitro.
    Hanicki Z; Cichocki T; Sarnecka-Keller M; Klein A; Komorowska Z
    Nephron; 1976; 17(1):73-80. PubMed ID: 934415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of several uremic parameters on uremic serum inhibition of lymphocyte blastogenesis.
    Modai D; Hadi Y; Weissgarten J; Peller S; Kaufman S
    Immunol Lett; 1985; 9(5):275-8. PubMed ID: 2987112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In-vitro reactivity of lymphocyte function in chronic uremia].
    Fan CD; Liu JY; Shou L; Huang HW
    Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):668-74. PubMed ID: 6594428
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of single oral dose of phenobarbitone on lymphocyte blastogenic response in man.
    Puppo F; Adami GF; Corsini G; Zavarise GM; Zattoni J
    Br J Anaesth; 1980 Dec; 52(12):1205-7. PubMed ID: 7448099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is serum urea a good index for predicting morbidity in hemodialysis (HD)?
    Marcén R; Lamas S; Quereda C; Orofino L; Teruel JL; Matesanz R; Ortuño J
    Adv Exp Med Biol; 1987; 223():245-7. PubMed ID: 3447441
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro stimulation of lymphocyte by PHA in whole blood method (author's transl)].
    Urabe Y; Fujii M; Ohnoshi T; Kimura I
    Rinsho Byori; 1977 Jul; 25(7):554-8. PubMed ID: 916243
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on middle molecules in uremia (author's transl)].
    Sanaka T
    Nihon Jinzo Gakkai Shi; 1978 Jun; 20(6):593-610. PubMed ID: 739656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.